{"schema_version":"1","generated_at":"2026-10-30T20:11:43.236Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/nikki-levin","json_url":"https://www.findmykol.com/kol/nikki-levin/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"nikki-levin","name":"Nikki Levin","credential":"MD","title":"Professor, UMass Chan Medical School","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"UMass Chan Medical School","institution_url":"https://www.findmykol.com/institution/umass-chan-medical-school","city":"Worcester","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1548243470","orcid":"0000-0002-5072-0423","openalex":"A5061177144"},"summary":"Nikki Levin is Professor, UMass Chan Medical School at UMass Chan Medical School. OpenAlex indexes 56 publications with 1,120 citations (h-index 17).","overview":{"text":"Nikki Levin, M.D., is Professor, UMass Chan Medical School. The public record shows 56 publications with 1,120 citations (h-index 17), centered on Dermatology and Skin Diseases, Acne and Rosacea Treatments and Effects, Medicine and Dermatology Studies History.","bullets":["Most recent indexed publication: 2022 · The British journal of dermatology","Top research focus: Dermatology and Skin Diseases"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Psoriasis / Psoriatic Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":1,"strength":1},{"label":"Atopic Dermatitis / Eczema","therapeutic_area":"Dermatology","trials":0,"topics":1,"strength":1},{"label":"Psoriasis (Derm)","therapeutic_area":"Dermatology","trials":0,"topics":1,"strength":1}],"research_topics":["Dermatology and Skin Diseases","Acne and Rosacea Treatments and Effects","Medicine and Dermatology Studies History","Psoriasis: Treatment and Pathogenesis","Dermatological diseases and infestations"]},"scholarship":{"works_count":56,"cited_by_count":1120,"h_index":17,"i10_index":21,"pubmed_count":1,"latest_activity_year":2022,"source":"works"},"trials":{"count":0,"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"company_count":0,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1548243470","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":27.7,"classes_total":3,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":22.5,"drugs":[{"name":"Ketoconazole","share_pct":100}],"max_beneficiaries":54},{"class":"Tetracycline-class Drug","setting":"prescribed","share_pct":2.9,"drugs":[{"name":"Doxycycline Hyclate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":22.2,"classes_total":5,"classes":[{"class":"Phosphodiesterase 4 Inhibitor","setting":"prescribed","share_pct":7,"drugs":[{"name":"Otezla","share_pct":100}],"max_beneficiaries":null},{"class":"Interleukin-12 Antagonist","setting":"prescribed","share_pct":5.2,"drugs":[{"name":"Stelara","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":20.3,"classes_total":3,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":13.9,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":84.1},{"name":"Fluocinolone Acetonide","share_pct":15.9}],"max_beneficiaries":null},{"class":"Interleukin-4 Receptor alpha Antagonist","setting":"prescribed","share_pct":4,"drugs":[{"name":"Dupixent Pen","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"publications":{"total":1,"shown":1,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Psoriasis and hidradenitis suppurativa are associated with inflammatory bowel disease: a growing body of evidence.","year":2022,"journal":"The British journal of dermatology","types":["Journal Article","Comment"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/35975655/","status":"verified"}],"most_cited":{"total":56,"shown":5,"withheld":51,"rows":[{"title":"Pigmented epithelioid melanocytoma","year":2006,"cited_by_count":206,"type":"article","source_url":"https://doi.org/10.1111/j.1365-4632.2006.02883.x"},{"title":"Identification of novel regions of altered DNA copy number in small cell lung tumors","year":1995,"cited_by_count":93,"type":"article","source_url":"https://doi.org/10.1002/gcc.2870130307"},{"title":"Frequent novel DNA copy number increase in squamous cell head and neck tumors.","year":1995,"cited_by_count":90,"type":"article","source_url":"https://openalex.org/A5061177144"},{"title":"Identification of frequent novel genetic alterations in small cell lung carcinoma.","year":1994,"cited_by_count":88,"type":"article","source_url":"https://openalex.org/A5061177144"},{"title":"A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest.","year":1993,"cited_by_count":74,"type":"article","source_url":"https://doi.org/10.1093/genetics/133.4.799"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"APRIL C. DENG","coauthored_works":10},{"name":"Michael F. Christman","coauthored_works":7},{"name":"Yuying Zhang","coauthored_works":6,"profile_url":"https://www.findmykol.com/kol/yuying-zhang-cn-2"}],"source":"works"},"similar":[{"name":"Timothy McAlindon","slug":"timothy-mcalindon","institution":"UMass Chan Medical School","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/timothy-mcalindon","json_url":"https://www.findmykol.com/kol/timothy-mcalindon/profile.json"},{"name":"Anil Chandraker","slug":"anil-chandraker","institution":"UMass Chan Medical School","specialty":"Nephrology","url":"https://www.findmykol.com/kol/anil-chandraker","json_url":"https://www.findmykol.com/kol/anil-chandraker/profile.json"},{"name":"Nils Henninger","slug":"nils-henninger","institution":"UMass Chan Medical School","specialty":"Neurology","url":"https://www.findmykol.com/kol/nils-henninger","json_url":"https://www.findmykol.com/kol/nils-henninger/profile.json"},{"name":"Nancy Byatt","slug":"nancy-byatt","institution":"UMass Chan Medical School","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/nancy-byatt","json_url":"https://www.findmykol.com/kol/nancy-byatt/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Victoria Werth","slug":"victoria-werth","institution":"Perelman School of Medicine at the University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/victoria-werth","json_url":"https://www.findmykol.com/kol/victoria-werth/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}